aTyr Pharma, Inc. [LIFE] is following upward trend in the market concluded with the last trading session. The shares of the Healthcare sector company has a current value of $0.39 after LIFE shares went up by 2.66% during the last trading session. One of the reasons why Healthcare stocks may go bullish is increased momentum in the press.
aTyr Pharma, Inc. [NASDAQ:LIFE]: Analyst Rating and Earnings
Stock traders often pay close attention what Wall Street analysts have to say about a potential investment. For aTyr Pharma, Inc. [LIFE], the latest consensus recommendation available followed its financial results for the fiscal quarter ending in December. On average, stock market experts give LIFE an Hold rating. Its stock price has been found in the range of 0.36 to 1.37. This is compared to its latest closing price of $0.38.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for aTyr Pharma, Inc. [LIFE] is sitting at 3.00. This is compared to 1 month ago, when its average rating was 3.00.
Keep an eye out for the next scheduled publication date for this company’s financial results, which are expected to be released on Tue 13 Aug (In 60 Days).
Fundamental Analysis of aTyr Pharma, Inc. [LIFE]
Turning to investigate this organization’s capital structure, aTyr Pharma, Inc. [LIFE] has generated a Total Debt to Total Equity ratio of 47.64. Similarly, its Total Debt to Total Capital is 32.27, while its Total Debt to Total Assets stands at 30.39. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 24.56, and its Long-Term Debt to Total Capital is 16.63. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.
What about valuation? This company’s Enterprise Value to EBITDA is 0.62. Total Debt to Enterprise Value stands at -0.86. aTyr Pharma, Inc. [LIFE] has a Price to Book Ratio of 0.45.
This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.69 and its Current Ratio is 4.69. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
aTyr Pharma, Inc. [LIFE] has 45.64M shares outstanding, amounting to a total market cap of $17.80M. Its stock price has been found in the range of 0.36 to 1.37. At its current price, it has moved down by -71.46% from its 52-week high, and it has moved up 7.73% from its 52-week low.
This stock’s Beta value is currently 2.56, which indicates that it is 7.18% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 33.74. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is aTyr Pharma, Inc. [LIFE] a Reliable Buy?
aTyr Pharma, Inc. [LIFE] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.